Can Ki-67 Play a Role in Prediction of Breast Cancer Patients' Response to Neoadjuvant Chemotherapy?

Table 4

Ki-67 as a function of molecular subtypes.

	Total	pCR yes	pCR no	𝑃
Triple negative	𝑛=23	𝑛=5	𝑛=19	𝑃=0.651
	60.4 ± 18.3	57 ± 18.5	61 ± 18.7
Her2 positive	𝑛=20	𝑛=11	𝑛=9	𝑃=0.576
	25.4 ± 12.6	23.9 ± 10.2	27.2 ± 15.6
Luminal	𝑛=33	𝑛=4	𝑛=29	P   =  0.001
	22 ± 19.5	50 ± 36.5	18.1 ± 12.9
	P   <  0.0001